eFFECTOR Therapeutics (EFTR) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free EFTR Stock Alerts $2.03 -0.11 (-5.14%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media eFFECTOR Therapeutics Stock Price Performance5 Day Performance-4.69%1 Month Performance-9.17%3 Month Performance-81.03%6 Month Performance-86.24%Year-To-Date Performance-82.63%1 Year Performance-85.03% Receive EFTR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. EFTR Stock Chart for Saturday, May, 11, 2024 EFTR Chart by TradingView eFFECTOR Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$2.14$2.03-5.14%$2.13$2.0085,384 shs$7.49 million05/09/2024$2.08$2.14+2.88%$2.14$1.98116,174 shs$7.90 million05/08/2024$2.05$2.08+1.46%$2.13$1.96118,184 shs$7.68 million05/07/2024$2.13$2.05-3.76%$2.23$2.0385,707 shs$7.56 million05/06/2024$2.20$2.13-3.18%$2.26$2.1079,789 shs$7.86 million05/03/2024$2.16$2.20+1.85%$2.29$2.12144,738 shs$8.12 million Get the Latest News and Ratings for EFTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$2.20$2.16-1.82%$2.26$2.08108,638 shs$7.97 million05/01/2024$2.25$2.20-2.22%$2.34$2.1762,982 shs$8.12 million04/30/2024$2.07$2.25+8.70%$2.27$2.02163,235 shs$8.30 million04/29/2024$1.89$2.07+9.52%$2.13$1.92226,008 shs$7.64 million04/26/2024$1.81$1.89+4.42%$1.96$1.81162,102 shs$6.97 million04/25/2024$1.85$1.81-2.16%$1.87$1.76180,331 shs$6.68 million04/24/2024$1.94$1.85-4.64%$1.94$1.80108,175 shs$6.83 million04/23/2024$1.78$1.94+8.99%$1.99$1.78149,612 shs$7.16 million04/22/2024$1.70$1.78+4.71%$1.87$1.63177,202 shs$6.57 million04/19/2024$1.78$1.70-4.49%$1.80$1.60197,040 shs$6.27 million04/18/2024$1.89$1.78-5.82%$1.91$1.75146,037 shs$6.56 million04/17/2024$1.99$1.89-5.03%$2.05$1.81135,489 shs$6.97 million04/16/2024$1.93$1.99+3.11%$2.03$1.89234,361 shs$7.34 million04/15/2024$2.08$1.93-7.21%$2.12$1.83412,408 shs$7.12 million04/12/2024$2.24$2.08-6.94%$2.27$2.03294,182 shs$7.68 million04/11/2024$2.36$2.24-5.30%$2.37$2.17324,974 shs$8.25 million04/10/2024$2.31$2.36+2.16%$2.39$2.24250,584 shs$8.71 million04/09/2024$2.13$2.31+8.45%$2.46$2.14817,552 shs$8.52 million04/08/2024$2.51$2.13-15.14%$2.44$2.101.33 million shs$5.51 million04/05/2024$2.96$2.51-15.20%$2.95$2.492.39 million shs$6.48 million04/04/2024$16.47$2.96-82.03%$4.10$2.768.68 million shs$7.65 million04/03/2024$15.41$16.47+6.88%$16.88$15.07246,976 shs$42.49 million04/02/2024$15.67$15.41-1.66%$15.88$14.26126,383 shs$39.76 million04/01/2024$14.39$15.67+8.90%$16.55$13.96349,734 shs$40.43 million03/29/2024$14.39$14.39$14.72$13.25351,762 shs$37.20 million03/28/2024$13.45$14.39+6.99%$14.72$13.25349,809 shs$37.13 million03/27/2024$12.91$13.45+4.18%$13.72$12.38164,295 shs$34.70 million03/26/2024$13.76$12.91-6.18%$13.49$11.10487,632 shs$33.31 million03/25/2024$12.33$13.76+11.60%$14.28$12.55311,272 shs$35.50 million03/22/2024$12.95$12.33-4.79%$12.91$12.0185,328 shs$31.81 million03/21/2024$12.85$12.95+0.78%$13.15$11.69143,661 shs$33.41 million03/20/2024$12.27$12.85+4.73%$12.85$12.0557,417 shs$33.15 million03/19/2024$11.87$12.27+3.37%$12.95$11.7179,580 shs$31.72 million03/18/2024$11.06$11.87+7.32%$13.15$11.30156,590 shs$30.63 millionThe A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself.03/15/2024$10.85$11.06+1.94%$11.33$10.83114,477 shs$28.54 million03/14/2024$10.88$10.85-0.28%$11.27$10.7575,258 shs$28.05 million03/13/2024$11.15$10.88-2.42%$11.55$10.50127,487 shs$28.07 million03/12/2024$11.12$11.15+0.27%$11.83$10.51158,505 shs$28.77 million03/11/2024$13.16$11.12-15.50%$13.62$10.85413,575 shs$28.69 million03/08/2024$14.99$13.16-12.21%$15.25$12.36464,988 shs$33.95 million03/07/2024$16.68$14.99-10.13%$16.74$14.93158,895 shs$38.67 million03/06/2024$15.57$16.68+7.13%$16.92$15.38173,090 shs$43.03 million03/05/2024$16.95$15.57-8.14%$17.22$15.11264,664 shs$40.25 million03/04/2024$16.20$16.95+4.63%$17.75$16.01310,264 shs$43.73 million03/01/2024$14.44$16.20+12.19%$16.59$14.05291,815 shs$41.80 million02/29/2024$13.59$14.44+6.25%$14.44$12.81161,885 shs$37.26 million02/28/2024$13.14$13.59+3.42%$15.00$13.44343,044 shs$35.06 million02/27/2024$11.62$13.14+13.08%$13.52$11.62360,376 shs$33.90 million02/26/2024$11.12$11.62+4.54%$11.92$11.03100,284 shs$29.98 million02/23/2024$11.04$11.11+0.63%$11.27$10.7477,812 shs$28.66 million02/22/2024$10.84$11.04+1.85%$11.29$10.5377,773 shs$28.48 million02/21/2024$10.99$10.84-1.36%$11.34$10.4268,042 shs$27.97 million02/20/2024$11.32$10.99-2.92%$11.93$10.60101,943 shs$28.41 million02/19/2024$11.32$11.32$11.90$11.2561,200 shs$29.21 million02/16/2024$11.66$11.32-2.92%$11.90$11.2561,278 shs$29.21 million02/15/2024$12.19$11.66-4.35%$12.64$11.29136,845 shs$30.14 million02/14/2024$10.99$12.19+10.92%$12.27$10.47203,885 shs$31.45 million02/13/2024$10.77$10.99+2.04%$11.43$10.6255,598 shs$28.35 million02/12/2024$10.70$10.77+0.65%$11.09$10.4086,753 shs$27.79 million Related Companies: Vaccinex Stock Price Chart Hepion Pharmaceuticals Stock Price Chart Cyclerion Therapeutics Stock Price Chart Universe Pharmaceuticals Stock Price Chart Pasithea Therapeutics Stock Price Chart Can-Fite BioPharma Stock Price Chart Bionomics Stock Price Chart Virios Therapeutics Stock Price Chart Cadrenal Therapeutics Stock Price Chart Processa Pharmaceuticals Stock Price Chart Receive EFTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EFTR) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.